MARKET

BIOAF

BIOAF

Bioasis Tech
EXMKT
0.0001
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
7.94K
P/E (TTM)
-0.0036
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIOAF last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at BIOAF last week (1117-1121)?
Weekly Report · 11/24 09:35
Weekly Report: what happened at BIOAF last week (1110-1114)?
Weekly Report · 11/17 09:36
Weekly Report: what happened at BIOAF last week (1103-1107)?
Weekly Report · 11/10 09:35
Weekly Report: what happened at BIOAF last week (1027-1031)?
Weekly Report · 11/03 09:34
Weekly Report: what happened at BIOAF last week (1020-1024)?
Weekly Report · 10/27 09:36
Weekly Report: what happened at BIOAF last week (1013-1017)?
Weekly Report · 10/20 09:35
Weekly Report: what happened at BIOAF last week (1006-1010)?
Weekly Report · 10/13 09:35
More
About BIOAF
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

Webull offers biOasis Technologies Inc stock information, including EXMKT: BIOAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOAF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOAF stock methods without spending real money on the virtual paper trading platform.